These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33860365)

  • 41. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
    Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
    Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
    mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV Persistence in Adipose Tissue Reservoirs.
    Couturier J; Lewis DE
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mathematical Models of HIV-1 Dynamics, Transcription, and Latency.
    D'Orso I; Forst CV
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.
    Gornalusse GG; Valdez R; Fenkart G; Vojtech L; Fleming LM; Pandey U; Hughes SM; Levy CN; Dela Cruz EJ; Calienes FL; Kirby AC; Fialkow MF; Lentz GM; Wagoner J; Jing L; Koelle DM; Polyak SJ; Fredricks DN; McElrath MJ; Wald A; Hladik F
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modelling coupled within host and population dynamics of [Formula: see text] and [Formula: see text] HIV infection.
    Manda EC; Chirove F
    J Math Biol; 2018 Apr; 76(5):1123-1158. PubMed ID: 28762130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals.
    Zoufaly A; Kiepe JG; Hertling S; Hüfner A; Degen O; Feldt T; Schmiedel S; Kurowski M; van Lunzen J
    HIV Med; 2014 Sep; 15(8):449-57. PubMed ID: 24580846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
    Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
    PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.
    Spivak AM; Andrade A; Eisele E; Hoh R; Bacchetti P; Bumpus NN; Emad F; Buckheit R; McCance-Katz EF; Lai J; Kennedy M; Chander G; Siliciano RF; Siliciano JD; Deeks SG
    Clin Infect Dis; 2014 Mar; 58(6):883-90. PubMed ID: 24336828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-7 promotes HIV persistence during antiretroviral therapy.
    Vandergeeten C; Fromentin R; DaFonseca S; Lawani MB; Sereti I; Lederman MM; Ramgopal M; Routy JP; Sékaly RP; Chomont N
    Blood; 2013 May; 121(21):4321-9. PubMed ID: 23589672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.